摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-methylbutanamide | 351458-95-2

中文名称
——
中文别名
——
英文名称
(S)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-methylbutanamide
英文别名
(S)-3-(tert-butyldimethylsilyloxy)-N-methoxy-N-methylbutyramide;(S)-N-methoxy-N-methyl-3-tert-butyldimethylsilyloxybutyramide;(3S)-3-[tert-butyl(dimethyl)silyl]oxy-N-methoxy-N-methylbutanamide
(S)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-methylbutanamide化学式
CAS
351458-95-2
化学式
C12H27NO3Si
mdl
——
分子量
261.437
InChiKey
SPWYQOFPTZBOJN-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.81
  • 重原子数:
    17
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    38.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (S)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-methylbutanamide 在 palladium diacetate 四氯化硅lithium diisopropyl amide 作用下, 以 四氢呋喃乙醚正己烷二氯甲烷 为溶剂, 反应 13.0h, 生成 (4S)-4-(tert-butyldimethylsilyloxy)-2-trichlorosilyloxy-1-pentene
    参考文献:
    名称:
    Lewis碱中遥远的立体中心的影响催化了手性三氯甲硅烷基烯醇酸酯的羟醛加成。
    摘要:
    在磷酰胺催化的醛醇缩合反应中采用带有较远的立体生成中心的手性三氯甲硅烷基烯醇盐。甲基酮烯酸酯的添加仅具有中等的非对映选择性。将Z-烯酸酯添加到各种醛中选择性地产生了顺式相对非对映异构体。在这两种情况下,β-甲硅烷氧基立体异构中心的作用均不明显,内部非对映异构主要由催化剂控制。[反应:看文字]
    DOI:
    10.1021/ol026594n
  • 作为产物:
    参考文献:
    名称:
    Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions
    摘要:
    We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the combination of changes to both the valine and aminal carbon region of elbasvir led to the discovery of a series of compounds with substantially improved potency against common resistance-associated substitutions in the major genotypes, as well as good pharmacokinetics in both rat and dog. Through further optimization of key leads from this effort, MK-6169 (21) was discovered as a preclinical candidate for further development.
    DOI:
    10.1021/acs.jmedchem.7b01927
点击查看最新优质反应信息

文献信息

  • TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
    申请人:Hutchinson John Howard
    公开号:US20070173508A1
    公开(公告)日:2007-07-26
    Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.
    本文描述了含有这些化合物的化合物和药物组合物,这些化合物抑制5-脂氧合酶(5-LO)的活性。本文还描述了使用这种5-LO抑制剂的方法,单独或与其他化合物结合,用于治疗呼吸系统、心血管系统和其他依赖或介导白三烯的状况、疾病或紊乱。
  • Approaches to 2-substituted chroman-4-ones: synthesis of (−)-pinostrobin
    作者:Kevin J Hodgetts
    DOI:10.1016/s0040-4039(01)00567-6
    日期:2001.5
    Two approaches to optically active 2-substituted chroman-4-ones are described. The first utilized the oxidation of a preformed chroman ring and the second an intramolecular Mitsunobu cyclization. The methodology was applied to the synthesis of the biologically active natural product (−)-pinostrobin (18).
    描述了两种光学活性的2-取代的苯并吡喃-4-酮的方法。第一种利用预先形成的苯并二氢吡喃环的氧化,第二种利用分子内光延环化。该方法被应用于生物活性天然产物(-)-pinostrobin(18)的合成。
  • Routes for the Synthesis of (2<i>S</i>)-2-Methyltetrahydropyran-4-one from Simple Optically Pure Building Blocks
    作者:Kevin R. Anderson、Stéphanie L. G. Atkinson、Takahiro Fujiwara、Melvyn E. Giles、Takaji Matsumoto、Eric Merifield、John T. Singleton、Takao Saito、Tsukasa Sotoguchi、James A. Tornos、Edward L. Way
    DOI:10.1021/op900163a
    日期:2010.1.15
    Routes to (2S)-2-methyltetrahydropyran-4-one of high optical purity starting from readily available chiral pool precursors and suitable for large-scale manufacture are described. In one approach, the key step is cyclisation of (S)-5-hydroxyhex-1-en-3-one, derived either from an alkyl (S)-3-hydroxybutyrate or (S)-propylene oxide. Formation of the tetrahydropyran ring directly via an intramolecular oxy-Michael
    描述了从容易获得的手性库前体开始并适于大规模生产的具有高光学纯度的(2S)-2-甲基四氢吡喃-4-酮的途径。在一种方法中,关键步骤是衍生自(S)-3-羟基丁酸烷基酯或(S)-环氧丙烷的(S)-5-羟基己-1-烯-3-酮的环化。在酸催化条件下直接通过分子内的氧-迈克尔反应形成四氢吡喃环导致光学纯度的损失,而通过中间体(2 S)-2-甲基-2,3-二氢吡喃-4-酮经由氧化的Pd催化的闭环反应,随后烯基键的氢化反应,保留了光学纯度。还报道了(2 S)-2-甲基-2,3-二氢吡喃-4-酮的另一种方法,该方法再次从(S)-3-羟基丁酸烷基酯精制为羰基保护的(6 S)- 6-甲基-5,6-二氢吡喃-2,4-二酮衍生物,然后部分还原并脱水。或者,可以在一步保护中将羰基完全还原掉,从而在脱保护后直接提供(2 S)-2-甲基四氢吡喃-4-酮。
  • Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions
    作者:Wensheng Yu、Ling Tong、Oleg Selyutin、Lei Chen、Bin Hu、Bin Zhong、Jinglai Hao、Tao Ji、Shuai Zan、Jingjun Yin、Rebecca T. Ruck、Stephanie Curry、Patricia McMonagle、Sony Agrawal、Laura Rokosz、Donna Carr、Paul Ingravallo、Karin Bystol、Frederick Lahser、Rong Liu、Shiying Chen、Kung-I Feng、Mark Cartwright、Ernest Asante-Appiah、Joseph A. Kozlowski
    DOI:10.1021/acs.jmedchem.7b01927
    日期:2018.5.10
    We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the combination of changes to both the valine and aminal carbon region of elbasvir led to the discovery of a series of compounds with substantially improved potency against common resistance-associated substitutions in the major genotypes, as well as good pharmacokinetics in both rat and dog. Through further optimization of key leads from this effort, MK-6169 (21) was discovered as a preclinical candidate for further development.
  • The Effects of a Remote Stereogenic Center in the Lewis Base Catalyzed Aldol Additions of Chiral Trichlorosilyl Enolates
    作者:Scott E. Denmark、Shinji Fujimori
    DOI:10.1021/ol026594n
    日期:2002.10.1
    Chiral trichlorosilyl enolates bearing a remote stereogenic center were employed in the phosphoramide-catalyzed aldol reaction. The additions of the methyl ketone enolates proceeded with only moderate diastereoselectivities. The addition of the Z-enolate to various aldehydes selectively produced the syn relative diastereomers. In both cases, the effect of the beta-silyloxy stereogenic center was modest
    在磷酰胺催化的醛醇缩合反应中采用带有较远的立体生成中心的手性三氯甲硅烷基烯醇盐。甲基酮烯酸酯的添加仅具有中等的非对映选择性。将Z-烯酸酯添加到各种醛中选择性地产生了顺式相对非对映异构体。在这两种情况下,β-甲硅烷氧基立体异构中心的作用均不明显,内部非对映异构主要由催化剂控制。[反应:看文字]
查看更多

同类化合物

(2-溴乙氧基)-特丁基二甲基硅烷 骨化醇杂质DCP 马来酸双(三甲硅烷)酯 顺式-二氯二(二甲基硒醚)铂(II) 顺-N-(1-(2-乙氧基乙基)-3-甲基-4-哌啶基)-N-苯基苯酰胺 降钙素杂质13 降冰片烯基乙基三甲氧基硅烷 降冰片烯基乙基-POSS 间-氨基苯基三甲氧基硅烷 镁,氯[[二甲基(1-甲基乙氧基)甲硅烷基]甲基]- 锑,二溴三丁基- 铷,[三(三甲基甲硅烷基)甲基]- 铂(0)-1,3-二乙烯-1,1,3,3-四甲基二硅氧烷 钾(4-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}-1-丁炔-1-基)(三氟)硼酸酯(1-) 金刚烷基乙基三氯硅烷 辛醛,8-[[(1,1-二甲基乙基)二甲基甲硅烷基]氧代]- 辛甲基-1,4-二氧杂-2,3,5,6-四硅杂环己烷 辛基铵甲烷砷酸盐 辛基衍生化硅胶(C8)ZORBAX?LP100/40C8 辛基硅三醇 辛基甲基二乙氧基硅烷 辛基三甲氧基硅烷 辛基三氯硅烷 辛基(三苯基)硅烷 辛乙基三硅氧烷 路易氏剂-3 路易氏剂-2 路易士剂 试剂3-[Tris(trimethylsiloxy)silyl]propylvinylcarbamate 试剂2-(Trimethylsilyl)cyclopent-2-en-1-one 试剂11-Azidoundecyltriethoxysilane 西甲硅油杂质14 衣康酸二(三甲基硅基)酯 苯胺,4-[2-(三乙氧基甲硅烷基)乙基]- 苯磺酸,羟基-,盐,单钠聚合甲醛,1,3,5-三嗪-2,4,6-三胺和脲 苯甲醇,a-[(三苯代甲硅烷基)甲基]- 苯基二甲基氯硅烷 苯基二甲基乙氧基硅 苯基乙酰氧基三甲基硅烷 苯基三辛基硅烷 苯基三甲氧基硅烷 苯基三乙氧基硅烷 苯基三丁酮肟基硅烷 苯基三(异丙烯氧基)硅烷 苯基三(2,2,2-三氟乙氧基)硅烷 苯基(3-氯丙基)二氯硅烷 苯基(1-哌啶基)甲硫酮 苯乙基三苯基硅烷 苯丙基乙基聚甲基硅氧烷 苯-1,3,5-三基三(三甲基硅烷)